Clinical trials involved treating patients with Tamiflu, which is a medicine intended to attack the influenza virus and stop it from causing flu symptoms.Among 958 patients treated with Tamiflu, 153 experienced nausea as an adverse reaction.Use a significance level of 0.05 to test the claim that the rate of nausea experienced by patients who were given Tamiflu is higher than the 12% rate experienced by flu patients who were given a placebo.